Neuravi Introduces Collaborative Clot Research Initiative At ESMINT Conference In September

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GALWAY, Ireland--(BUSINESS WIRE)--Neuravi, a developer of innovative stroke therapy, announced today that it will introduce the Neuravi Thromboembolic Initiative (NTI) during a series of workshops on “The Science of Clot” at the upcoming European Society of Minimally Invasive Neurological Therapy (ESMINT) conference in Nice. The NTI brings together Neuravi engineers with clinicians and researchers from leading international institutions in an effort to deepen the understanding of the mechanical properties of clot and occlusion dynamics, with the goal of improving the physician’s ability to restore flow in acute ischemic stroke.

Help employers find you! Check out all the jobs and post your resume.

Back to news